| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 13 |
| 1 | METHOTREXATE | 11 |
| 2 | AZACITIDINE | 4 |
| 3 | AZACITIDINE FOR | 4 |
| 4 | FOLIC ACID | 4 |
| 5 | VENETOCLAX | 4 |
| 6 | LUSPATERCEPT | 2 |
| 7 | ALLOPURINOL | 1 |
| 8 | ASPIRIN | 1 |
| 9 | ASPIRIN 325 MG | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LUSPATERCEPT | 2 | 0.0008 |
| 1 | DEFEROXAMINE MESYLATE | 1 | 0.0005 |
| 2 | AVATROMBOPAG MALEATE | 1 | 0.0004 |
| 3 | CROMOLYN SODIUM | 1 | 0.0003 |
| 4 | AZACITIDINE | 4 | 0.0001 |
| 5 | DASATINIB | 1 | 0.0001 |
| 6 | VENETOCLAX | 4 | 0.0001 |
| 7 | PANITUMUMAB | 1 | 0.0001 |
| 8 | MERCAPTOPURINE | 1 | 0.0001 |
| 9 | LAMIVUDINE | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Folate Analog Metabolic Inhibitor [EPC] | 11 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 5 |
| 2 | BCL-2 Inhibitor [EPC] | 4 |
| 3 | Vitamin B12 [EPC] | 4 |
| 4 | Vitamin C [EPC] | 4 |
| 5 | Vitamin D [EPC] | 4 |
| 6 | Erythroid Maturation Agent [EPC] | 2 |
| 7 | Platinum-based Drug [EPC] | 2 |
| 8 | Angiotensin Converting Enzyme Inhibitor [EPC] | 1 |
| 9 | Anti-epileptic Agent [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Erythroid Maturation Agent [EPC] | 2 | 0.0008 |
| 1 | BCL-2 Inhibitor [EPC] | 4 | 0.0001 |
| 2 | Iron Chelator [EPC] | 1 | 0.0000 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 11 | 0.0000 |
| 4 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |
| 5 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Central alpha-2 Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 5 | 0.0000 |
| 8 | HER2/neu Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | Vitamin D [EPC] | 4 | 0.0000 |